Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000568820

Apexbio Technology LLC EPRODISATE-DISODIUM-500MG
SDP

Catalog No. 5000568820
Encompass_Preferred

Eprodisate disodium (CAS No 36589-58-9) is a compound studied primarily within the field of biomedical research It originates as a synthetic molecule designed for therapeutic intervention in amyloid-related diseases Eprodisate disodium functions by inhibiting the polymerization of amyloid fibrils specifically targeting the interaction between amyloid proteins and glycosaminoglycans which are crucial pathways in disease progression Its activity is commonly observed in the nanomolar to low micromolar range indicating potent efficacy The compound is frequently utilized in cell models and animal studies for investigating amyloid inhibition and can be instrumental in drug screening processes Experimental concentrations typically depend on the specific research design Such studies aim to validate its potential as a therapeutic agent enhancing the understanding of diseases characterized by amyloid accumulation

Catalog No. 50-005-68820 Supplier Apexbio Technology LLC Supplier No. C6472500
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Eprodisate disodium (CAS No 36589-58-9) is a compound studied primarily within the field of biomedical research It originates as a synthetic molecule designed for therapeutic intervention in amyloid-related diseases Eprodisate disodium functions by inhibiting the polymerization of amyloid fibrils specifically targeting the interaction between amyloid proteins and glycosaminoglycans which are crucial pathways in disease progression Its activity is commonly observed in the nanomolar to low micromolar range indicating potent efficacy The compound is frequently utilized in cell models and animal studies for investigating amyloid inhibition and can be instrumental in drug screening processes Experimental concentrations typically depend on the specific research design Such studies aim to validate its potential as a therapeutic agent enhancing the understanding of diseases characterized by amyloid accumulation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.